Log in to save to my catalogue

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding protei...

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding protei...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8f7cccfd89b4f9fab6bc8144d9c6b8c

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity

About this item

Full title

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity

Publisher

United States: John Wiley & Sons, Inc

Journal title

Pulmonary circulation, 2022-04, Vol.12 (2), p.e12039-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by sustained elevations of pulmonary artery pressure. To date, we lack circulating, diagnostic, and prognostic markers that correlate to clinical and functional parameters. In this study, we performed mass spectrometry‐based proteomics analysis to identify circulating biom...

Alternative Titles

Full title

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d8f7cccfd89b4f9fab6bc8144d9c6b8c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8f7cccfd89b4f9fab6bc8144d9c6b8c

Other Identifiers

ISSN

2045-8940,2045-8932

E-ISSN

2045-8940

DOI

10.1002/pul2.12039

How to access this item